# ADCs Sector

Canonical URL: https://biopharmsignal.com/sector/adcs

ADCs, or antibody-drug conjugates, combine the targeting ability of antibodies with the payload of a cytotoxic drug. This sector page groups companies working on ADC platforms or lead ADC assets, especially in oncology where the modality has become increasingly important.

Companies currently grouped under ADCs: 7

## Recent Sector News

- 2026-09-01 12:00 EST — LEGN — [Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference](https://biopharmsignal.com/news/LEGN/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference-9365884f) — Source: Legend Biotech Corporation
- 2026-08-12 11:00 EST — STRO — [Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study](https://biopharmsignal.com/news/STRO/sutro-biopharma-reports-second-quarter-2026-financial-results-and-provides-early-6048b54d) — Source: Sutro Biopharma
- 2026-08-11 11:00 EST — LEGN — [Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights](https://biopharmsignal.com/news/LEGN/legend-biotech-reports-second-quarter-2026-results-and-recent-highlights-e2e82cac) — Source: Legend Biotech Corporation
- 2026-07-28 12:00 EST — LEGN — [Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results](https://biopharmsignal.com/news/LEGN/legend-biotech-to-host-investor-conference-call-on-second-quarter-2026-results-3744bba0) — Source: Legend Biotech Corporation
- 2026-07-27 10:00 EST — LEGN — [Legend Biotech Announces CEO Transition](https://biopharmsignal.com/news/LEGN/legend-biotech-announces-ceo-transition-6f26346e) — Source: Legend Biotech Corporation
- 2026-06-18 01:21 EST — LEGN — [Legend Biotech Corporation Announces Pricing of Public Offering](https://biopharmsignal.com/news/LEGN/legend-biotech-corporation-announces-pricing-of-public-offering-c0ab1d0b) — Source: Legend Biotech Corporation
- 2026-06-17 20:29 EST — LEGN — [Legend Biotech Corporation Announces Proposed Public Offering](https://biopharmsignal.com/news/LEGN/legend-biotech-corporation-announces-proposed-public-offering-3615b70e) — Source: Legend Biotech Corporation
- 2026-06-15 12:00 EST — LEGN — [Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma](https://biopharmsignal.com/news/LEGN/legend-biotech-establishes-clinical-proof-of-concept-for-lb2501-a-potential-firs-fb89efa6) — Source: Legend Biotech Corporation
- 2026-06-02 13:30 EST — LEGN — [Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)](https://biopharmsignal.com/news/LEGN/legend-biotech-announces-late-breaking-oral-presentation-at-eha-2026-showcasing--075d2e3b) — Source: Legend Biotech Corporation
- 2026-06-01 14:00 EST — LEGN — [Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026](https://biopharmsignal.com/news/LEGN/legend-biotech-presents-first-in-human-lb2102-results-in-solid-tumors-and-new-ca-f6f84458) — Source: Legend Biotech Corporation
- 2026-05-21 21:00 EST — LEGN — [Legend Biotech Announces Presentations at ASCO 2026](https://biopharmsignal.com/news/LEGN/legend-biotech-announces-presentations-at-asco-2026-b3367a52) — Source: Legend Biotech Corporation
- 2026-05-14 20:05 EST — STRO — [Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights](https://biopharmsignal.com/news/STRO/sutro-biopharma-reports-first-quarter-2026-financial-results-and-business-highli-43d18eb3) — Source: Sutro Biopharma
- 2026-05-12 11:00 EST — LEGN — [Legend Biotech Reports First Quarter 2026 Results and Recent Highlights](https://biopharmsignal.com/news/LEGN/legend-biotech-reports-first-quarter-2026-results-and-recent-highlights-a43caca4) — Source: Legend Biotech Corporation
- 2026-05-04 12:00 EST — LEGN — [Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth](https://biopharmsignal.com/news/LEGN/legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth-806c85a2) — Source: Legend Biotech Corporation
- 2026-04-28 12:00 EST — LEGN — [Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results](https://biopharmsignal.com/news/LEGN/legend-biotech-to-host-investor-conference-call-on-first-quarter-2026-results-5d0924a1) — Source: Legend Biotech Corporation
- 2026-04-19 23:45 EST — STRO — [Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026](https://biopharmsignal.com/news/STRO/sutro-biopharma-presents-promising-preclinical-data-across-its-pipeline-of-next--bdf8f4ce) — Source: Sutro Biopharma
- 2026-03-23 20:05 EST — STRO — [Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights](https://biopharmsignal.com/news/STRO/sutro-biopharma-reports-full-year-2025-financial-results-and-business-highlights-c81ab4c5) — Source: Sutro Biopharma
- 2026-03-10 11:00 EST — LEGN — [Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights](https://biopharmsignal.com/news/LEGN/legend-biotech-reports-fourth-quarter-and-full-year-2025-results-and-recent-high-0e5399b6) — Source: Legend Biotech Corporation
- 2026-02-25 13:30 EST — STRO — [Sutro Biopharma to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/STRO/sutro-biopharma-to-participate-in-upcoming-investor-conferences-5470cd63) — Source: Sutro Biopharma
- 2026-02-24 13:00 EST — LEGN — [Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results](https://biopharmsignal.com/news/LEGN/legend-biotech-to-host-investor-conference-call-on-fourth-quarter-and-full-year--7e132942) — Source: Legend Biotech Corporation

## Companies

- [ADCT](https://biopharmsignal.com/company/ADCT) — ADC Therapeutics
- [AMAM](https://biopharmsignal.com/company/AMAM) — Ambrx Biopharma
- [IMGN](https://biopharmsignal.com/company/IMGN) — ImmunoGen
- [LEGN](https://biopharmsignal.com/company/LEGN) — Legend Biotech Corporation
- [MRSN](https://biopharmsignal.com/company/MRSN) — Mersana Therapeutics
- [STRO](https://biopharmsignal.com/company/STRO) — Sutro Biopharma
- [VINC](https://biopharmsignal.com/company/VINC) — Vincerx Pharma